Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model

► First proved low dose rupintrivir protects from lethal EV71 infection in vivo. ► Rupintrivir effectively alleviates EV71 induced pathologies in vivo. ► Previous safety records justify its immediate clinical trial In HFMD.